Healthcare Stocks
Healthcare covers pharmaceuticals, biotech, medical devices, managed care, and hospitals. Patent cliffs, regulatory risk, and binary clinical outcomes distort reported earnings, so we lean on cash-based valuation (Price/FCF, EV/EBITDA) and multi-year revenue durability when ranking this sector. Biotech pre-revenue names often screen poorly on Value — that's by design.
Top 50 Healthcare Stocks by StockRank
| # | Ticker | Company | Mkt Cap | Score | Q | V | M |
|---|---|---|---|---|---|---|---|
| 1 | PHIL.MI | Philogen S.p.A. | $1.1B | 100 | 94 | 82 | 74 |
| 2 | 1526.HK | Rici Healthcare Holdings Limited | $182M | 100 | 70 | 89 | 76 |
| 3 | HLUN-A.CO | H. Lundbeck A/S | $5.5B | 100 | 74 | 84 | 78 |
| 4 | 1830.HK | Perfect Medical Health Management Limited | $171M | 100 | 80 | 80 | 67 |
| 5 | 2877.HK | China Shineway Pharmaceutical Group Limited | $716M | 100 | 76 | 94 | 59 |
| 6 | 3600.HK | Modern Dental Group Limited | $697M | 100 | 81 | 77 | 70 |
| 7 | BMY.MX | Bristol-Myers Squibb Company | $120.4B | 100 | 75 | 82 | 72 |
| 8 | GXH.NZ | Green Cross Health Limited | $159M | 100 | 63 | 80 | 87 |
| 9 | 001540.KQ | Ahn-Gook Pharmaceutical Co., Ltd. | $70M | 100 | 70 | 89 | 67 |
| 10 | 096760.KS | JW Holdings Corporation | $161M | 100 | 73 | 94 | 59 |
| 11 | 0157.KL | Focus Point Holdings Berhad | $77M | 100 | 77 | 86 | 61 |
| 12 | DR.TO | Medical Facilities Corporation | $223M | 100 | 75 | 81 | 68 |
| 13 | NUTX | Nutex Health Inc. | $1.1B | 100 | 81 | 73 | 70 |
| 14 | 2279.HK | Yonghe Medical Group Co., Ltd. | $132M | 100 | 74 | 91 | 57 |
| 15 | 7792.T | Colan Totte.Co.,Ltd. | $81M | 100 | 87 | 75 | 62 |
| 16 | ASCN.SW | Ascom Holding AG | $251M | 100 | 76 | 74 | 73 |
| 17 | PRM.MC | Prim, S.A. | $260M | 100 | 79 | 77 | 67 |
| 18 | VISTN.OL | Vistin Pharma ASA | $93M | 100 | 89 | 75 | 59 |
| 19 | 600351.SS | Yabao Pharmaceutical Group Co., Ltd | $581M | 99 | 81 | 80 | 59 |
| 20 | 1681.HK | Consun Pharmaceutical Group Limited | $1.3B | 99 | 87 | 82 | 50 |
| 21 | 2219.HK | Chaoju Eye Care Holdings Limited | $207M | 99 | 64 | 91 | 64 |
| 22 | HLUN-B.CO | H. Lundbeck A/S | $6.3B | 99 | 74 | 79 | 66 |
| 23 | NTC.JO | Netcare Limited | $1.2B | 99 | 68 | 76 | 75 |
| 24 | 8432.TWO | TSH Biopharm Corporation Limited | $61M | 99 | 82 | 84 | 52 |
| 25 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.9B | 99 | 87 | 52 | 79 |
| 26 | BOI.PA | Boiron SA | $558M | 99 | 74 | 83 | 60 |
| 27 | M12.DE | M1 Kliniken AG | $404M | 99 | 78 | 72 | 67 |
| 28 | BRM.DE | Bristol-Myers Squibb Company | $117.1B | 99 | 73 | 67 | 78 |
| 29 | DRW8.DE | Drägerwerk AG & Co. KGaA | $1.5B | 99 | 70 | 88 | 58 |
| 30 | 3839.HK | Chia Tai Enterprises International Limited | $246M | 99 | 69 | 71 | 75 |
| 31 | 600479.SS | ZhuZhou QianJin Pharmaceutical Co.,Ltd | $684M | 99 | 72 | 75 | 68 |
| 32 | 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $2.5B | 99 | 72 | 77 | 65 |
| 33 | HRMY | Harmony Biosciences Holdings, Inc. | $2.1B | 99 | 78 | 65 | 71 |
| 34 | 2689.T | OLBA HEALTHCARE HOLDINGS, Inc. | $74M | 99 | 62 | 91 | 60 |
| 35 | 4320.T | CE Holdings Co.,Ltd. | $181M | 99 | 75 | 61 | 77 |
| 36 | MED.DE | MEDICLIN Aktiengesellschaft | $214M | 99 | 58 | 86 | 68 |
| 37 | 1513.HK | Livzon Pharmaceutical Group Inc. | $2.6B | 99 | 80 | 86 | 46 |
| 38 | BMY | Bristol-Myers Squibb Company | $117.5B | 99 | 74 | 68 | 70 |
| 39 | DRW3.DE | Drägerwerk AG & Co. KGaA | $1.8B | 98 | 70 | 85 | 57 |
| 40 | 002001.SZ | Zhejiang NHU Company Ltd. | $13.4B | 98 | 77 | 69 | 64 |
| 41 | IRWD | Ironwood Pharmaceuticals, Inc. | $680M | 98 | 79 | 68 | 63 |
| 42 | RIGL | Rigel Pharmaceuticals, Inc. | $716M | 98 | 83 | 76 | 52 |
| 43 | 000423.SZ | Dong-E-E-Jiao Co., Ltd. | $4.1B | 98 | 86 | 67 | 58 |
| 44 | OGN | Organon & Co. | $3.5B | 98 | 58 | 70 | 82 |
| 45 | 3320.HK | China Resources Pharmaceutical Group Limited | $3.5B | 98 | 58 | 93 | 59 |
| 46 | CI.MX | The Cigna Group | $75.2B | 98 | 55 | 86 | 69 |
| 47 | LNA.PA | LNA Santé SA | $399M | 98 | 51 | 76 | 83 |
| 48 | 600566.SS | Hubei Jumpcan Pharmaceutical Co., Ltd. | $3.4B | 98 | 72 | 75 | 61 |
| 49 | INCY | Incyte Corporation | $22.7B | 98 | 86 | 45 | 77 |
| 50 | 600267.SS | Zhejiang Hisun Pharmaceutical Co., Ltd. | $1.7B | 98 | 69 | 77 | 62 |
Other Sectors
Technology
Software, semiconductors, cloud, and platform businesses ranked by Quality, Value, and Momentum.
Financial Services
Banks, insurers, asset managers, and exchanges ranked on Quality, Value, and Momentum.
Consumer Cyclical
Autos, retail, travel, and apparel — cyclical consumer names ranked by MoatMap.
Consumer Defensive
Food, beverage, household products, and discount retail — stable demand businesses.
Industrials
Aerospace, machinery, defence, transportation, and logistics ranked by Quality, Value, and Momentum.
Energy
Oil & gas, refining, pipelines, and energy services ranked by MoatMap.
Basic Materials
Mining, metals, chemicals, and building materials ranked on Quality, Value, and Momentum.
Utilities
Regulated electric, gas, water, and renewable utilities ranked by MoatMap.
Real Estate
REITs across residential, commercial, industrial, and data centre property ranked by MoatMap.
Communication Services
Telecom, media, interactive entertainment, and internet platforms ranked by MoatMap.